Trial
NCT06536465
The Clostridioides Difficile Trial of REC-3964
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Recursion Pharmaceuticals Inc.
Collaborators
—
Condition
Recurrent Clostridioides Difficile Infection
Intervention
REC-3964
Why stopped
Study was terminated due to sponsor decision. This decision was not related to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-17